Fibromyalgia
Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system
SYNOPSIS
We present epidemiological, clinical and experimental evidence that Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) constitutes a major type of adverse effect of vaccines, especially those containing poorly degradable particulate aluminum adjuvants.
CITATION
Romain K. Gherardi, Guillemette Crepeaux, Francois-Jerome Authier; Autoimmunity Reviews, Volume 18, Issue 7, July 2019, Pages 691-705.
SUMMARY
Evidence showed Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) constitutes a major type of adverse effect of vaccines, especially those containing poorly degradable particulate aluminum adjuvants. It was supported by an epidemiological study comparing vaccinated vs unvaccinated militaries and revealed affected patients suffer from cognitive dysfunction affecting attention, memory and inter-hemispheric connexions, well correlated to brain perfusion defects and associated with a stereotyped and distinctive pattern of cerebral glucose hypometabolism. Instead of being rapidly solubilized in the extracellular space, injected aluminum particles are quickly captured by immune cells and transported to distant organs and the brain where they elicit an inflammatory response and exert selective low dose long-term neurotoxicity.